NASDAQ$VREX

Varex Imaging Corp · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Reported financial results for the third quarter of fiscal year 2021.

Varex Imaging Corporation announced its Q3 fiscal year 2021 results with revenues of $211 million, a 23% increase year-over-year, driven by demand in both the Medical and Industrial segments. GAAP net earnings were $0.29 per diluted share and non-GAAP net earnings were $0.40 per diluted share. Cash and cash equivalents improved $17 million sequentially to $128 million.

  • Revenues reached $211 million, driven by demand in both the Medical and Industrial segments.
  • Revenues increased 4% sequentially from the second quarter of fiscal year 2021 due mainly to sales gains in the Medical segment.
  • Revenues increased 23% year-over-year from the same quarter of the prior year driven by strength in both the Medical and Industrial segments.
  • Cash and cash equivalents improved $17 million sequentially to $128 million at the end of the third quarter.

Headline financials

Total Revenue

$211M

Previous: $171M+23.4%
EPS (adj)

$0.40

Previous: -$0.20+300.0%
Non-GAAP Gross Margin

36.0%

No prior period
Non-GAAP Operating Margin

14.0%

No prior period
Capital Expenditures

-$12.5M

Previous: -$19.5M+35.9%
Free Cash Flow

-$500K

Previous: -$47.8M+99.0%
Net Income

$12M

Previous: -$28.3M+142.4%
Operating Income

$25.7M

Previous: -$26.8M+195.9%
Gross Profit

$74.1M

Previous: $26.3M+181.7%
Cash & Equivalents

$128M

Previous: $87.4M+46.8%
Total Assets

$1.16B

Previous: $1.12B+3.5%
Stock-Based Comp

$3.4M

Previous: $3.7M-8.1%

Revenue & EPS history

Varex Imaging · Revenue · Quarterly

$211M

Q3 2021+23.4%vs Q3 2020
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Revenue by segment

Varex Imaging · $211M total across 2 segments · Q3 2021

  • Medical
    $167M+21.6%
  • Industrial
    $43.9M+30.7%

Forward guidance

The following guidance is provided for the fourth quarter of fiscal year 2021: Revenues are expected to be between $205 million and $225 million and Non-GAAP net earnings per diluted share is expected to be between $0.25 and $0.40.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

-4.3%

Avg return

Earnings day

-3.4%

Avg return

5 days after

-3.0%

Avg return

30 days after

37%

15 / 41 earnings

Positive

+22.1%

Q1 2021

Best reaction

-34.7%

Q2 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026-16.9%-14.9%
Q1 2026-3.8%-4.5%-23.6%
Q4 2025-13.7%-7.1%+3.6%
Q2 2025-20.5%-13.9%-2.7%
Q1 2025-19.3%-11.6%-15.7%
Q4 2024+9.2%+17.8%+1.8%
Q3 2024-12.2%-21.2%-15.6%
Q2 2024-6.0%-4.4%-6.8%
Q1 2024-8.4%-8.4%-8.6%
Q4 2023+3.1%+1.7%+12.7%
Q3 2023-3.8%-2.6%-15.5%
Q2 2023+17.6%+25.5%+25.6%
Q1 2023-10.0%-7.2%-14.6%
Q4 2022+3.8%-1.6%-10.7%
Q3 2022+4.1%-0.6%-0.3%
Q2 2022+11.5%+11.5%+15.8%
Q1 2022-5.3%-8.6%-4.8%
Q4 2021+17.1%+15.0%+8.7%
Q3 2021+1.9%+7.3%+10.2%
Q2 2021+2.6%+2.0%+6.1%
Q1 2021+22.1%+19.3%+21.0%
Q4 2020-3.2%+1.0%+16.6%
Q3 2020-21.2%-21.1%-34.3%
Q2 2020-34.7%-32.9%-38.3%
Q1 2020-5.3%-5.3%-25.3%
Q4 2019-9.7%-7.5%-3.5%
Q3 2019-15.8%-13.3%-5.0%
Q2 2019-9.1%-8.1%-16.4%
Q1 2019+15.7%+8.8%+15.0%
Q4 2018-8.3%-1.8%-10.8%
Q3 2018-25.7%-25.5%-17.8%
Q2 2018-1.6%-0.3%+1.1%
Q1 2018-18.5%-15.9%-15.8%
Q4 2015-1.2%-0.2%+7.2%
Q4 2017+1.8%+2.6%+10.3%
Q3 2016+0.8%-0.2%+9.4%
Q3 2017-8.2%-5.1%+1.3%
Q2 2016+0.2%+0.2%-3.3%
Q2 2017+0.7%+1.2%+3.0%
Q1 2017-2.4%-5.1%-0.3%
Q4 2016-2.4%-5.1%-0.3%
Q1 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro